| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,762 |
12,824 |
$944K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,147 |
6,544 |
$332K |
| 90834 |
Psychotherapy, 45 minutes with patient |
2,513 |
1,424 |
$154K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
654 |
556 |
$51K |
| 90837 |
Psychotherapy, 53 minutes with patient |
413 |
248 |
$42K |
| 36415 |
Collection of venous blood by venipuncture |
9,893 |
9,037 |
$26K |
| 99215 |
Prolong outpt/office vis |
264 |
251 |
$26K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,219 |
1,208 |
$24K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
343 |
339 |
$21K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
216 |
214 |
$16K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,608 |
1,574 |
$16K |
| 90686 |
|
2,367 |
2,314 |
$15K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
422 |
360 |
$14K |
| 80061 |
Lipid panel |
1,115 |
1,092 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
689 |
665 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
69 |
68 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,018 |
997 |
$8K |
| X5622 |
|
967 |
944 |
$6K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
216 |
214 |
$5K |
| 80053 |
Comprehensive metabolic panel |
552 |
544 |
$5K |
| 92551 |
|
870 |
861 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
663 |
648 |
$5K |
| 99188 |
|
589 |
584 |
$4K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
102 |
101 |
$4K |
| 0071A |
|
85 |
79 |
$3K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,020 |
1,993 |
$3K |
| 0054A |
|
62 |
62 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
43 |
42 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
47 |
45 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
37 |
37 |
$2K |
| 0004A |
|
87 |
84 |
$2K |
| G0008 |
Administration of influenza virus vaccine |
440 |
400 |
$2K |
| 0072A |
|
38 |
37 |
$1K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
289 |
278 |
$1K |
| 85027 |
|
353 |
343 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
28 |
25 |
$1K |
| 80050 |
General health panel |
27 |
27 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
72 |
70 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
67 |
65 |
$1K |
| 90694 |
|
34 |
27 |
$868.91 |
| 99173 |
|
752 |
746 |
$852.53 |
| 85018 |
|
350 |
333 |
$647.44 |
| 90653 |
|
52 |
47 |
$569.12 |
| 0011A |
|
38 |
38 |
$564.12 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
53 |
52 |
$547.96 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
14 |
14 |
$528.91 |
| 82728 |
|
37 |
37 |
$494.11 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
16 |
14 |
$450.38 |
| 77080 |
|
19 |
13 |
$445.96 |
| 0012A |
|
24 |
24 |
$366.76 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
56 |
56 |
$354.38 |
| 90480 |
|
15 |
15 |
$317.90 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12 |
12 |
$305.28 |
| 90656 |
|
26 |
26 |
$285.28 |
| 90670 |
|
99 |
98 |
$284.51 |
| 96127 |
|
114 |
112 |
$278.66 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
37 |
37 |
$254.16 |
| 82607 |
|
15 |
14 |
$238.77 |
| 0031A |
|
15 |
15 |
$224.32 |
| 86803 |
|
13 |
13 |
$185.32 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
59 |
59 |
$177.45 |
| 36416 |
|
180 |
152 |
$158.94 |
| 99442 |
|
15 |
14 |
$54.57 |
| 81001 |
|
51 |
50 |
$52.68 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
36 |
36 |
$0.00 |
| 90651 |
|
32 |
32 |
$0.00 |
| 90723 |
|
38 |
38 |
$0.00 |
| 90734 |
|
13 |
12 |
$0.00 |
| 81003 |
|
16 |
16 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
51 |
50 |
$0.00 |
| 99177 |
|
26 |
25 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
16 |
16 |
$0.00 |